Intrexon bets $26M on stem cells, teams up with troubled OvaScience

Damian Garde

, a Maryland biotech backed by billionaire RJ Kirk, has agreed to snap up San Diego regenerative medicine outfit for $ 26 million, and the company inked a separate agreement with to combine their technology platforms.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS